cagrisema semaglutide cagrilintide phase 3 results 2024 2025 obesity drug: what the data shows CagriSema Achieves 22.7% Weight Loss – Novo Nordisk's CagriSema outperforms Ozempic

10.1176/appi.ajp.160.7.1298 Am

Here at Mason Park Medical Clinic, our providers are trained in assessing your overall health and determining the best weight loss medication to help you achieve your health goals

How Blood Sugar Changes Can Trigger Palpitations Semaglutide is a GLP-1 receptor agonist

Further studies have shown that Tirzepatide is generally well-tolerated with mild side effects that subside over time

Medication alone cannot replace healthy habits

In pregnant women with uncontrolled diabetes, excessive blood glucose can significantly impair the development of crucial fetal organs, such as the brain, heart, kidneys, and lungs